Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CTMX

CytomX Therapeutics Inc

May 29 • 03:16PM ET

3.56

-0.15 -4.04 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IDYA RCUS TNGX CGON NUVL KYMR RYTM BMRN INCY KRYS

| Held by: VTI XBI VXF IBB FDM VHT FFSM LABU DFAS IDNA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.36	Insider Own	23.26%	Shs Outstand	217.69M	Perf Week	-5.31%
Market Cap	775.09M	Forward P/E	-	EPS next Y	-0.52	Insider Trans	-0.38%	Shs Float	167.07M	Perf Month	-12.09%
Enterprise Value	431.24M	PEG	-	EPS next Q	-0.08	Inst Own	81.47%	Short Float	18.64%	Perf Quarter	-33.70%
Income	-62.14M	P/S	21.81	EPS this Y	-186.30%	Inst Trans	25.59%	Short Ratio	4.57	Perf Half Y	-14.21%
Sales	35.54M	P/B	2.42	EPS next Y	-22.11%	ROA	-25.83%	Short Interest	31.13M	Perf YTD	-16.42%
Book/sh	1.47	P/C	2.24	EPS next 5Y	-	ROE	-34.29%	52W High	8.21 -56.63%	Perf Year	41.28%
Cash/sh	1.59	P/FCF	-	EPS past 3/5Y	53.93% 27.00%	ROIC	-18.48%	52W Low	1.72 106.99%	Perf 3Y	104.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.75% -5.36%	Gross Margin	96.51%	Volatility	4.73% 5.30%	Perf 5Y	-50.28%
Dividend TTM	-	EV/Sales	12.13	EPS Y/Y TTM	-173.33%	Oper. Margin	-182.20%	ATR (14)	0.22	Perf 10Y	-66.48%
Dividend Ex-Date	-	Quick Ratio	10.38	Sales Y/Y TTM	-75.91%	Profit Margin	-174.84%	RSI (14)	35.50	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	10.38	EPS Q/Q	-138.13%	SMA20	-7.07%	Beta	2.09	Target Price	12.44
Payout	-	Debt/Eq	0.01	Sales Q/Q	-79.85%	SMA50	-15.44%	Rel Volume	0.20	Prev Close	3.71
Employees	69	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	-10.61%	Avg Volume	6.81M	Price	3.56
IPO	Oct 08, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.42% 119.08%	Trades		Volume	1,212,639	Change	-4.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)